Physician profile
David A Duchene
NPI 1548261860
$33,064.99
in general payments reported to CMS, 2019-2025
18 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $4,327 · 2021: $4,374 · 2022: $4,264 · 2023: $630 · 2024: $8,726 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,750 · Travel and Lodging: $2,665 · Food and Beverage: $1,101 · Honoraria: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,750.00 |
| Travel and Lodging | $2,664.52 |
| Food and Beverage | $1,100.67 |
| Honoraria | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $31,209.30 | 2019-2024 | |
| Boston Scientific Corporation | $460.83 | 2019-2025 | Ams 700 |
| Medtronic, INC. | $279.05 | 2022-2023 | Interstim |
| Cook Incorporated | $250.00 | 2023 | |
| Karl Storz Endoscopy-America | $192.64 | 2020-2023 | Flex-X |
| Ethicon US, LLC | $192.19 | 2019-2025 | Echelon Endopath, Vistaseal |
| Histosonics, INC. | $127.27 | 2025 | |
| Merck Sharp & Dohme LLC | $87.10 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.92 | 2021 | |
| Janssen Biotech, INC. | $49.47 | 2019 | |
| Abbvie INC. | $22.04 | 2019 | |
| Rochester Medical Corporation | $21.07 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $19.88 | 2022 | |
| Baxter Healthcare | $16.13 | 2024 | Perclot |
| Astellas Pharma US INC | $15.85 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $15.45 | 2023 | |
| Cook Medical LLC | $13.94 | 2020 | |
| Travere Therapeutics, INC. | $9.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Duchene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.